EAM
RVNC

Exome Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Exome Asset Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-347,600
Closed -$1.8M – 82
2024
Q3 		$1.8M Buy
+347,600
New +$1.8M 1.22% 36